Skip to main content
. Author manuscript; available in PMC: 2021 Aug 1.
Published in final edited form as: Br J Haematol. 2020 Mar 2;190(3):405–417. doi: 10.1111/bjh.16530

Figure 7: Targeting SPHK2 with ABC294640 synergizes with ABT-199 to decrease proliferation in LGL leukemia cells.

Figure 7:

A) NKL cells were treated with increasing doses of ABT-199 in the presence or absence of 25 μM ABC294640 and cell viability was assessed using MTS assay. B) Combinatorial index (CI) was calculated for ABT-199 with ABC294640. CI values less than 1 indicate synergy between the compounds.